OTC Pharmaceuticals - Europe

  • Europe
  • The revenue generated by the OTC Pharmaceuticals market in Europe is estimated to be US$54.44bn in 2024.
  • It is projected to experience an annual growth rate of 3.85% (CAGR 2024-2029).
  • Among the various markets, the largest one is Other OTC Pharmaceuticals, with a market volume of US$15.56bn in 2024.
  • In terms of global comparison, the in the United States generates the highest revenue, with US$41,240.00m in 2024.
  • When considering the population, the per person revenue in Europe is approximately US$64.51 in 2024.
  • Online sales are expected to contribute 15.86% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • In Europe, Germany leads the OTC Pharmaceuticals market with a strong emphasis on herbal remedies and natural health products.

Key regions: United States, China, Germany, Japan, Europe

Region comparison

Analyst Opinion

The OTC Pharmaceuticals market in Europe is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to this positive trend.Customer preferences in Europe are shifting towards self-medication and convenience. Consumers are increasingly looking for over-the-counter solutions for common health issues, such as headaches, colds, and allergies. They prefer the convenience of purchasing these medications without a prescription, as it saves them time and money. In addition, the aging population in Europe is driving the demand for OTC pharmaceuticals, as older individuals often require medications for chronic conditions that can be managed with over-the-counter products.Trends in the market are also contributing to the growth of the OTC Pharmaceuticals market in Europe. One major trend is the increasing availability and variety of OTC products. Pharmaceutical companies are expanding their product portfolios to include a wider range of OTC medications, catering to different consumer needs. This includes products for specific age groups, such as children or the elderly, as well as products targeted towards specific health conditions, such as digestive issues or sleep disorders. Additionally, the rise of e-commerce and online pharmacies has made it easier for consumers to access and purchase OTC medications, further driving market growth.Local special circumstances in Europe are also impacting the OTC Pharmaceuticals market. Each country in Europe has its own regulations and healthcare systems, which can influence the availability and accessibility of OTC medications. Some countries have more liberal regulations, allowing for a wider range of OTC products to be sold, while others have stricter regulations that limit the availability of certain medications. Additionally, the presence of national healthcare systems in some countries can affect consumer preferences, as individuals may rely more on prescription medications covered by their insurance.Underlying macroeconomic factors are also playing a role in the development of the OTC Pharmaceuticals market in Europe. The overall economic growth and stability in the region have increased consumers' purchasing power, making OTC medications more affordable and accessible. In addition, the increasing prevalence of chronic diseases, such as diabetes and cardiovascular conditions, is driving the demand for OTC medications that can help manage these conditions. The growing awareness and focus on preventive healthcare and self-care are also contributing to the growth of the OTC Pharmaceuticals market in Europe.Overall, the OTC Pharmaceuticals market in Europe is experiencing growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The shift towards self-medication, the increasing availability of OTC products, and the convenience of online purchasing are all driving market growth. The different regulations and healthcare systems in each country, as well as the economic stability and prevalence of chronic diseases, are also influencing the development of the market.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.


  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)